| Date | Subject |
| 06/20/2008 02:42:24 PM | |
| Rolofylline Reduces Congestion and Improves Renal Function for Patients Hospitalised With Acute Heart Failure and Volume Overload: Presented at HF2008 |
| 06/20/2008 08:56:04 AM | |
| Bosentan Reduces Clinical Decline of Patients With Early-Stage Pulmonary Arterial Hypertension |
| 06/20/2008 08:52:43 AM | |
| Aciclovir Does Not Reduce HIV Acquisition in Women or Gay Men With Genital Herpes |
| 06/20/2008 08:49:57 AM | |
| New Oral Drug Laquinimod Appears to Reduce Disease Activity in Patients With Relapse-Remitting MS |
| 06/19/2008 04:21:08 PM | |
| Incident Dementia Reduced by Antihypertensive Therapy in Elderly Hypertensive Patients: Presented at ESH |
| 06/19/2008 04:17:28 PM | |
| Morbidity and Mortality Benefits of Antihypertensive Therapy Shown for All Major Subgroups in Elderly: Presented at ESH |
| 06/19/2008 04:14:17 PM | |
| Kidney Transplant Patients Benefit From Calcineurin Inhibitor Withdrawal Regimen |
| 06/19/2008 04:11:55 PM | |
| Metformin Improves Insulin Sensitivity, Promotes Weight Loss, and Provides Improved Cholesterol Control for Obese Children With Insulin Resistance: Presented at ENDO 08 |
| 06/19/2008 04:08:22 PM | |
| Aliskiren Produces Sustained Blood Pressure Reduction Even After Missed Dose: Presented at ESH |
| 06/19/2008 04:05:13 PM | |
| Nonadherence to Antiepileptic Drugs Associated With Increased Mortality |
| 06/19/2008 09:22:55 AM | |
| Hypertension Treatment Effective in Reversing Vascular Damage |
| 06/19/2008 09:19:59 AM | |
| Allopurinol Improves Diastolic Function and Lowers NT-proBNP Levels in Heart Failure Patients: Presented at HF2008 |
| 06/19/2008 09:15:50 AM | |
| Ivabradine Improves Heart Rate and Left-Ventricular Function in Patients With Severe Systolic Chronic Heart Failure on Beta-Blockers: Presented at HF2008 |
| 06/18/2008 05:46:52 PM | |
| Gene Variation Explains Ineffectiveness of Cholesterol-Lowering Drugs in Some Patients |
| 06/18/2008 05:46:39 PM | |
| Piboserod Improves Left-Ventricular Function in Patients With Symptomatic Heart Failure: Presented at HF2008 |
| 06/18/2008 03:59:29 PM | |
| Bisoprolol and Enalapril Monotherapies Have Similar Efficacies in Mild to Moderate Chronic Heart Failure: Presented at HF2008 |
| 06/18/2008 03:57:01 PM | |
| Rosuvastatin Increases Endothelial Progenitor Cells in Patients With Heart Failure: Presented at HF2008 |
| 06/18/2008 03:53:45 PM | |
| Hypertension Remains a Predictor of Cardiovascular Risk Even After Lipid-Lowering Therapy: Presented at ESH |
| 06/18/2008 03:51:37 PM | |
| Gene Mutation Improves Leukaemia Drug's Effect |
| 06/18/2008 03:48:40 PM | |
| Amlodipine Reduces Left Ventricular Hypertrophy Better Than Atenolol: Presented at ESH |
| 06/18/2008 03:45:40 PM | |
| Anticoagulants Comparable for Venous Thromboembolism Prevention in Myeloma Patients Receiving Thalidomide Regimens: Presented at EHA |
| 06/18/2008 03:24:28 PM | |
| FDA Requests Boxed Warnings on Conventional Antipsychotic Drugs |
| 06/17/2008 05:35:52 PM | |
| Interferon-Beta May Have Disease Modifying Effect in Patients With B19-Positive Inflammatory Cardiomyopathy: Presented at HF2008 |
| 06/17/2008 05:24:55 PM | |
| Dasatinib Benefits Children and Adolescents With Relapsed or Refractory Leukaemia: Presented at EHA |
| 06/17/2008 05:23:10 PM | |
| TGA Approves Panvax, Avian Flu Vaccine |
| 06/17/2008 05:19:27 PM | |
| Frontline Dasatinib Demonstrates Rapid Response in Patients With Previously Untreated Chronic-Phase Chronic Myeloid Leukaemia: Presented at EHA |
| 06/17/2008 05:17:20 PM | |
| High-Dose Imatinib Offers No Additional Benefit to Standard Dose as First-Line Therapy for High-Risk Chronic-Phase Chronic Myeloid Leukaemia: Presented at EHA |
| 06/17/2008 05:14:41 PM | |
| Dasatinib Monotherapy Effective and Feasible as First-Line Treatment of Adult Philadelphia-Chromosome Positive Acute Lymphoblastic Leukaemia: Presented at EHA |
| 06/17/2008 01:07:56 PM | |
| Etanercept Plus Methotrexate Prevents Joint Damage in Early Active Rheumatoid Arthritis: Presented at EULAR |
| 06/17/2008 01:05:43 PM | |
| Melphalan, Prednisone, and Thalidomide Combo Improves Progression-Free Survival but Not Overall Survival in Older Patients With Multiple Myeloma: Presented at EHA |
| 06/17/2008 12:42:40 PM | |
| Eculizumab Improves Fatigue Independent of Changes in Anaemia in Patients With Paroxysmal Nocturnal Haemoglobinuria: Presented at EHA |
| 06/17/2008 10:42:32 AM | |
| Cinaciguat Safely Improves Cardiopulmonary Haemodynamics in Acute Decompensated Heart Failure: Presented at HF2008 |
| 06/17/2008 10:30:56 AM | |
| FDA Approves Triamcinolone Acetone Formulation for Ocular Use |
| 06/16/2008 10:29:27 PM | |
| No Link Between Ibandronate and Atrial Fibrillation in Postmenopausal Osteoporosis Patients: Presented at EULAR |
| 06/16/2008 10:25:35 PM | |
| Oral Anticoagulant Dabigatran Etexilate Approved in Canada |
| 06/16/2008 10:23:00 PM | |
| Abatacept and Infliximab Improve ACR and LDAS in Methotrexate-Refractory RA Patients |
| 06/16/2008 10:20:37 PM | |
| Chinese Study: Carbocisteine Prevents COPD Exacerbations |
| 06/16/2008 10:11:39 PM | |
| Levosimendan Infusion Provides Prolonged Efficacy and Safety in Patients With Acute Heart Failure: Presented at HF2008 |
| 06/16/2008 05:44:21 PM | |
| Tocilizumab Tops Methotrexate Monotherapy in Rheumatoid Arthritis Patient-Reported Outcomes: Presented at EULAR |
| 06/16/2008 11:53:57 AM | |
| Bortezomib Added to Melphalan-Prednisone Significantly Improves Overall Survival in Previously Untreated Patients With Multiple Myeloma: Presented at EHA |
| 06/16/2008 11:50:54 AM | |
| Duloxetine Safety in Fibromyalgia Sustained Up to 60 Weeks and Comparable to Other Uses of the Drug: Presented at EULAR |
| 06/16/2008 11:47:03 AM | |
| Belimumab Effective in Patients With Serologically Active Systemic Lupus Erythematosus: Presented at EULAR |
| 06/16/2008 10:43:11 AM | |
| FDA Approves Duloxetine HCl for the Management of Fibromyalgia |
| 06/16/2008 08:55:08 AM | |
| Metformin Slows Early-Onset Puberty in Girls |
| 06/15/2008 06:35:22 PM | |
| High-Dose Imatinib Followed by Maintenance Not Significantly Different Than Continuous Standard-Dose Imatinib in Patients With Previously Treated Chronic Phase Chronic Myeloid Leukaemia: Presented at EHA |
| 06/15/2008 05:47:10 PM | |
| Tolvaptan Combo Therapy Provides Significant Advantage Over Therapy Alone in Treating Acute Heart Failure Syndromes: Presented at HF2008 |
| 06/15/2008 05:36:18 PM | |
| Intravenous Quercetin Significantly Reduces Mortality in STEMI: Presented at HF2008 |
| 06/15/2008 05:28:55 PM | |
| Tocilizumab Monotherapy Tops Methotrexate Monotherapy for Patients With Rheumatoid Arthritis: Presented at EULAR |
| 06/15/2008 05:26:35 PM | |
| Certolizumab Pegol Provides Important Benefits in Patients With Rheumatoid Arthritis: Presented at EULAR |
| 06/15/2008 05:23:54 PM | |
| Rituximab Retreatment Preflare Advised in Patients Responding to Rituximab After TNF Failure: Presented at EULAR |
| 06/15/2008 05:13:55 PM | |
| High-Dose Imatinib Offers No Benefit as First- Line Therapy for High-Risk Chronic-Phase CML: Presented at EHA |
| 06/15/2008 05:11:47 PM | |
| Interim Analysis: First-Line Nilotinib Effective in Patients With Chronic Myeloid Leukaemia: Presented at EHA |
| 06/15/2008 12:53:08 PM | |
| Bosutinib Induces Response in Patients With CML Resistant or Intolerant to Imatinib, Other TKIs: Presented at EHA |
| 06/15/2008 12:23:09 PM | |
| Consolidation With Radiolabeled MAb Delays Progression of Advanced Follicular Lymphoma: Presented at EHA |
| 06/15/2008 12:19:09 PM | |
| Tocilizumab Boosts Outcomes in Patients With Rheumatoid Arthritis Refractory to TNF-Antagonists: Presented at EULAR |
| 06/15/2008 12:13:31 PM | |
| Zoledronic Acid Better for Bone Remodelling Than Risedronate in Glucocorticoid-Induced Osteoporosis: Presented at EULAR |
| 06/15/2008 09:54:56 AM | |
| Adalimumab Demonstrates Long-Term Benefit in Ankylosing Spondylitis: Presented at EULAR |
| 06/15/2008 09:24:15 AM | |
| Infliximab Monotherapy Effective for Long-Term Treatment of Spondyloarthritis: Presented at EULAR |
| 06/15/2008 08:57:57 AM | |
| Dasatinib Benefits Patients With Chronic-Phase CML Failing Imatinib: Presented at EHA |
| 06/15/2008 08:55:12 AM | |
| High-Dose vs Standard-Dose Imatinib in Treatment-Naive Patients With Newly Diagnosed CML: Presented at EHA |
| 06/15/2008 08:53:22 AM | |
| Golimumab Effective in Patients With Rheumatoid Arthritis Not Responding to Methotrexate: Presented at EULAR |
| 06/15/2008 08:50:03 AM | |
| FDG-PET Useful in Tailoring Therapy for Patients With Advanced Hodgkin's Lymphoma: Presented at EHA |
| 06/15/2008 08:43:45 AM | |
| Intensive Induction Therapy Followed by Stem-Cell Support and Consolidation Therapy Produces High Responses in Elderly With Multiple Myeloma: Presented at EHA |
| 06/15/2008 08:40:05 AM | |
| Adalimumab Cuts Uveitis Flares: Presented at EULAR |
| 06/15/2008 08:29:02 AM | |
| Data Support Azacytidine as First-Line Therapy for Patients With High-Risk MDS: Presented at EHA |
| 06/14/2008 04:20:28 PM | |
| Adding Infliximab to Combination DMARD Treatment for Early Rheumatoid Arthritis Increases Remission Rate, Prevention of Radiological Progression: Presented at EULAR |
| 06/14/2008 02:08:14 PM | |
| Malignancies in Etanercept-Treated Patients Uncommon: Presented at EULAR |
| 06/13/2008 05:45:14 PM | |
| Rheumatoid Arthritis Patients Refractory to Anti-TNFs Achieve Disease Remission With Tocilizumab Plus Methotrexate |
| 06/13/2008 04:40:18 PM | |
| Teriparatide Tops Alendronate in Multiple Subgroups at Increased Fracture Risk: Presented at EULAR |
| 06/13/2008 04:30:39 PM | |
| Adalimumab Effective in Patients With Rheumatic Disease Unresponsive to Other Anti-TNF Therapies |
| 06/13/2008 03:26:42 PM | |
| Memantine Provides Significant Effects on 3 Key Cognitive Domains in Patients With Alzheimer's Disease: Presented at ENS |
| 06/13/2008 03:12:30 PM | |
| VNP40101M Plus Cytarabine Demonstrates Benefit Over Cytarabine Alone in Relapsed Acute Myelogenous Leukaemia: Presented at EHA |
| 06/13/2008 02:43:27 PM | |
| Eltrombopag Demonstrates Safety and Efficacy in Idiopathic Thrombocytopenic Purpura: Presented at EHA |
| 06/13/2008 02:37:21 PM | |
| Golimumab Effective for RA in Patients Who Discontinue Prior Anti-TNF-Alpha Therapy: Presented at EULAR |
| 06/13/2008 11:34:12 AM | |
| Lapatinib Approved in Europe for Breast Cancer |
| 06/13/2008 08:10:37 AM | |
| Pregabalin Results in Pain Relief in Fibromyalgia Patients: Presented at EULAR |
| 06/13/2008 08:07:29 AM | |
| Pregabalin Effective for Fibromyalgia Pain Regardless of Patient Anxiety or Depression: Presented at EULAR |
| 06/12/2008 04:20:13 PM | |
| Rituximab Maintains Inhibition of Structural Damage at 2 Years in Patients With Rheumatoid Arthritis: Presented at EULAR |
| 06/12/2008 04:16:49 PM | |
| Milnacipran Shows Good Results in Fibromyalgia Patients: Presented at EULAR |
| 06/12/2008 10:53:57 AM | |
| Sublingual Immunotherapy Benefits for Grass-Induced Asthma: Presented at EAACI |
| 06/12/2008 10:14:33 AM | |
| Dexamethasone Improves Outcomes in Bacterial Meningitis When Implemented According to Recommendations: Presented at ENS |
| 06/11/2008 10:11:34 PM | |
| Antihypertensive Treatment Can Significantly Slow Down Cognitive Decline in Alzheimer's Disease: Presented at ENS |
| 06/11/2008 03:23:39 PM | |
| Modified Islet Cell Transplantation Leads to Insulin Independence in Patients With Type 1 Diabetes |
| 06/11/2008 10:27:32 AM | |
| Once-Weekly Exenatide Shows Enduring Control of Diabetes: Presented at ADA |
| 06/11/2008 10:25:15 AM | |
| Pioglitazone Prevents Conversion to Diabetes Among Insulin-Resistant Patients: Presented at ADA |
| 06/10/2008 05:31:27 PM | |
| Mometasone Furoate Nasal Spray Improves Congestion Associated With Seasonal Allergic Rhinitis: Presented at EAACI |
| 06/10/2008 05:28:53 PM | |
| Desloratadine Reduces Patient-Rated Symptoms of Intermittent Allergic Rhinitis: Presented at EAACI |
| 06/10/2008 04:27:45 PM | |
| Short Course Immunotherapy Containing Monophosphoryl Lipid A Adjuvant Shows Good Long-Term Efficacy: Presented at EAACI |
| 06/10/2008 04:10:04 PM | |
| Raloxifene Reduces Risk of Invasive Estrogen Receptor-Positive Breast Cancer |
| 06/10/2008 03:56:23 PM | |
| Adherence to Disease-Modifying Therapy in Multiple Sclerosis Highest in Subcutaneous Interferon Beta-1a and Glatiramer Acetate: Presented at ENS |
| 06/10/2008 03:39:43 PM | |
| Fotemustine Shows Activity as Single Agent in Recurrent or Progressive Gliomas: Presented at ENS |
| 06/10/2008 03:36:57 PM | |
| Patients Rate Rupatadine, Ebastine, and Loratadine Effective in Treating Allergic Rhinitis: Presented at EAACI |
| 06/10/2008 11:59:42 AM | |
| Single Lot of Morphine Sulfate 60-mg Extended Release Tablets Recalled |
| 06/09/2008 05:44:16 PM | |
| Veterans Affairs Trial Fails to Establish Lower Haemoglobin as Protective Against Cardiovascular Events: Presented at ADA |
| 06/09/2008 05:04:40 PM | |
| Diabetes Medication Associated With Slower Progression of Retina Disease |
| 06/09/2008 05:00:23 PM | |
| Sitagliptin Lowers Risk of Hypoglycaemia in Type 2 Diabetes: Presented at ADA |
| 06/09/2008 04:58:41 PM | |
| Combination Sitagliptin and Metformin Shows Substantial Beta-Cell Function Improvement at 2 Years: Presented at ADA |
| 06/09/2008 04:56:53 PM | |
| High-Dose Cyclophosphamide Appears to Reduce Disease Activity, Disability in Patients With MS |
| 06/09/2008 04:51:16 PM | |
| Topiramate Reduces Heavy Drinking and Symptoms of Alcoholism |
| 06/09/2008 02:37:35 PM | |
| Liraglutide Provides Multiple Benefits Over Glimepiride in Type 2 Diabetes: Presented at ADA |
| 06/09/2008 02:34:49 PM | |
